top of page

Molnupiravir: a promising new treatment for COVID-19

Early studies show molnupiravir to be the first oral medication effective against SARS-CoV-2. Safe at therapeutic levels, its active intracellular form introduces lethal mutations in the virus but does not mutate host cell DNA. Developed at Emory University and marketed by Merck, it is most effective when given early in infection. Wikipedia offers an excellent new summary at . If further studies confirm the value of molnupiravir, this will be a valuable addition to the fight against COVID-19. However, the best course remains for all of us and our loved ones to get vaccinated, minimizing our chances to get infected or sick with COVID-19 in the first place.

10 views0 comments

Recent Posts

See All

Respiratory syncytial virus (RSV) infections are surging in Georgia at this time (September 2023), but new single-dose vaccines are now available by prescription and recommended for adults over age 60

WHO (World Health Organization) has just declared the widely used sweetener aspartame "possibly carcinogenic to humans." There they go again. To this day (1,2), no credible scientific evidence of aspa

SUBJECT: Georgia Chamber Music Retreat By: Laurie Searle (clarinet) I wanted to share my experience attending the Georgia Chamber Music Retreat this past weekend, as it may be something members of GMG

bottom of page